Regeneron Pharmaceuticals Receives FDA Complete Response Letter on EYLEA HD Extended Dosing Proposal
"Hope they can find a solution soon!"
"What are the next steps for Regeneron after this setback?"
"It's great to see such ongoing innovations in eye care."
"This is disappointing; I was hoping for longer intervals."
"Can anyone explain why the FDA rejected the proposal?"
"This is just part of the journey in drug development, right?"
"Sounds like a solid drug despite the delay."
"I'm curious about the potential side effects mentioned."
"Why is eye health still so overlooked in healthcare?"
"Regeneron has been doing amazing work in this area!"
"EYLEA HD sounds promising but I wonder about the competition."
2025-04-18T19:00:00.000Z
Erik Nilsson
Source of the news: www.globenewswire.com